Cell Microsystems

About:

Cell Microsystems develops, manufactures, and markets innovative products for single-cell biology.

Website: https://cellmicrosystems.com/

Twitter/X: CellMicrosys

Top Investors: National Institutes of Health, Small Business Innovation Research, NC IDEA, Telegraph Hill Partners

Description:

Cell Microsystems is an early-growth stage company that develops, manufactures, and markets innovative products for single-cell biology. The company’s proprietary CellRaft™ Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the company’s automated imaging platform, a user can select a cell in real time and ‘track and trace’ that cell through imaging, collection, and downstream analysis. By sorting during real-time imaging, no cells are wasted enabling single-cell isolation from even small, precious samples. The CellRaft Technology offers scalable solutions making cell separation technology available for every lab.

Total Funding Amount:

$30M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)cellmicrosystems.com

Founders:

Nancy Allbritton

Number of Employees:

11-50

Last Funding Date:

2023-08-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai